Basic Information
| LncRNA/CircRNA Name | LINC00844 |
| Synonyms | NA |
| Region | GRCh38_10:58999626-59001543 |
| Ensemble | ENSG00000237949 |
| Refseq | NR_108046 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | prostate cancer |
| ICD-0-3 | C61.9 |
| Methods | ChIP-seq, Microarray |
| Sample | prostate cancer tissues, cell lines(LNCaP, VCaP, 22Rv1) |
| Expression Pattern | down-regulated |
| Function Description | The expression of LINC00844 is higher in normal prostate compared with malignant and metastatic prostate cancer clinical specimens, and patients with low expression had a poor prognosis and significantly increased biochemical recurrence. |
| Pubmed ID | 30115758 |
| Year | 2018 |
| Title | Novel lncRNA LINC00844 Regulates Prostate Cancer Cell Migration and Invasion through AR Signaling. |
External Links
| Links for LINC00844 | GenBank HGNC NONCODE |
| Links for prostate cancer | OMIM COSMIC |